Doremon, Nelson .

HRN: 27-25-87  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2025
06/13/2025
IVT
500mg
Q6
Cholecystitis, T/c Cholangitis In Progression 2. HAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines